SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001472375-23-000024
Filing Date
2023-01-24
Accepted
2023-01-24 16:23:31
Documents
39
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT FOR THE PERIOD ENDED DECEMBER 31, 2022 ixform10q.htm   iXBRL 10-Q 323398
2 CERTIFICATION exhibit31-1.htm EX-31.1 11712
3 CERTIFICATION exhibit31-2.htm EX-31.2 12476
4 CERTIFICATION exhibit32-1.htm EX-32.1 5156
5 CERTIFICATION exhibit32-2.htm EX-32.2 5096
6 regenerexlogo.gif GRAPHIC 5716
  Complete submission text file 0001472375-23-000024.txt   1744222

Data Files

Seq Description Document Type Size
7 SCHEMA DOCUMENT reg1357878-20221231.xsd EX-101.SCH 14655
8 CALCULATION LINKBASE DOCUMENT reg1357878-20221231_cal.xml EX-101.CAL 26968
9 DEFINITION LINKBASE DOCUMENT reg1357878-20221231_def.xml EX-101.DEF 38177
10 LABELS LINKBASE DOCUMENT reg1357878-20221231_lab.xml EX-101.LAB 137551
11 PRESENTATION LINKBASE DOCUMENT reg1357878-20221231_pre.xml EX-101.PRE 106956
33 EXTRACTED XBRL INSTANCE DOCUMENT ixform10q_htm.xml XML 115114
Mailing Address 5348 VEGAS DRIVE #177 LAS VEGAS NV 89108
Business Address 5348 VEGAS DRIVE #177 LAS VEGAS NV 89108 (702) 805-7525
REGENEREX PHARMA, INC. (Filer) CIK: 0001357878 (see all company filings)

IRS No.: 980479983 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-53230 | Film No.: 23548407
SIC: 2834 Pharmaceutical Preparations